Skip to main content
. Author manuscript; available in PMC: 2022 Mar 22.
Published in final edited form as: Prog Mol Biol Transl Sci. 2020 Aug 28;175:77–119. doi: 10.1016/bs.pmbts.2020.07.001

Fig. 1.

Fig. 1

Mechanistic location of therapeutic targets for PrP prion diseases. Therapeutic targets: ❶ PrPC post-translational processing, metabolism, cellular trafficking, or localization; ❷ PrPC by binding or inducing conformational change that prevents PrPC interaction; ❸ PrPSc by stabilization, redistribution; ❹ conversion process by blocking binding site on PrPC, capping growth, inhibition of cofactor interactions, or ❺ promoting fragmentation or ❻ clearance from the host.